Frederick Lang
, Chair, Neurosurgery · University of Texas M D Anderson Cancer Center
Credentials: · · · ·
History
- Present
Neurosurgery Department · University of Texas M D Anderson Cancer Center
- 1989–1993
New York University Medical Center
- 1988–1989
New York University Medical Center
1984–1988
Research
Journal of neurosurgery · 2001 · 2,308 citations
The Lancet Oncology · 2009 · 1,995 citations
Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma
Cancer Cell · 2013 · 925 citations
- RS
67 papers
45 papers · 2 as a fellow
40 papers
38 papers
33 papers
29 papers
29 papers
25 papers
Grants
- 2008–2029
National Cancer Institute · P50
Contact PI · $28.4M · University of Tx Md Anderson Can Ctr
- 2020–2025
National Cancer Institute · R01
Contact PI · $2.2M · University of Tx Md Anderson Can Ctr
- 2017–2023
MSC-Derived Exosomes and MicroRNA in Glioma Therapy
National Cancer Institute · R01
Contact PI · $1.8M · University of Tx Md Anderson Can Ctr
- 2006–2012
Bone Marrow Stem Cells: Novel Treatment of Human Glioma
National Cancer Institute · R01
Contact PI · $1.3M · University of Tx Md Anderson Can Ctr
Clinical trials
- 2019–2027
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Principal investigator · Recruiting · Phase 1
M.D. Anderson Cancer Center
- 2014–2018
DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Principal investigator · Completed · Phase 1
DNAtrix, Inc.
- 2009–2015
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
Principal investigator · Completed · Phase 1
DNAtrix, Inc.
- 1998–2005
Principal investigator · Completed · Phase 3
M.D. Anderson Cancer Center